GEMINI THERAPEUTICS, INC.

Company

Disc Medicine, Inc.

Filed

October 11, 2022

Accession Number

0000902664-22-004509

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →